Previous close | 2.6400 |
Open | 2.5250 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 2.6400 - 2.6400 |
52-week range | 1.6900 - 3.1000 |
Volume | |
Avg. volume | 22,012 |
Market cap | 712.668M |
Beta (5Y monthly) | 0.93 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
PureTech Health (PRTC) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Our writer is itching to buy one FTSE 250 stock that ticks all of his boxes this month. The post Here’s one FTSE 250 stock I’d buy in April appeared first on The Motley Fool UK.
PureTech Health PLC Sponsored ADR (PRTC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.